The iShares Core Dividend Growth ETF (DGRO) is facing challenges as the 10-year Treasury yield approaches its 12-month high. This makes DGRO's dividend growth less attractive compared to risk-free Treasury notes. Investors should monitor the 10-year Treasury yield for movements below 4.25% or above 4.75%, as well as DGRO's December rebalance, particularly regarding Johnson & Johnson's weighting, which could significantly alter the fund's profile.
Vanguard High Dividend Yield ETF (VYM) manages $94.6 billion in assets, focusing on large-cap U.S. stocks with high dividend yields. Its top holdings, including Johnson & Johnson and Procter & Gamble, have strong dividend coverage and consistent payo...
The NEOS S&P 500 High Income ETF (SPYI) has returned 8% year-to-date and 19% over the past year, driven mainly by its 12% annualized distribution from selling call options on S&P 500 stocks. However, with market volatility (VIX) decreasing below its ...
Johnson & Johnson reported strong Q2 earnings, driven by a 41.1% year-on-year sales increase of its depression treatment Spravato, reaching $584 million. The company raised its 2026 adjusted diluted EPS guidance from $11.45-$11.65 to $11.6-$11.75, re...
Johnson & Johnson reported strong Q2 sales of $584 million for Spravato, a nasal spray for treatment-resistant depression, signaling robust market potential for psychedelic drugs. Jefferies highlights this growth supports the commercial viability of ...
Johnson & Johnson reported solid Q2 2026 results, achieving 6.6% annual revenue growth driven by strong Pharma and MedTech divisions. The company maintains a portfolio of over 15 blockbuster drugs and a promising pipeline, supporting its status as a ...
